ArticleDrug design, development and therapy2015

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.

Raffaella Palumbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.